http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109331107-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-333 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-53 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-481 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-714 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-264 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-296 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-896 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-896 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-714 |
| filingDate | 2018-11-26^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-08-10^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-08-10^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109331107-B |
| titleOfInvention | Traditional Chinese medicine composition and oral liquid for preventing and treating pet viral myocarditis and preparation method thereof |
| abstract | The invention relates to a traditional Chinese medicine composition for preventing and treating pet viral myocarditis, which comprises the following raw materials in parts by weight: 15-35 parts of astragalus; 10-25 parts of epimedium; 30-55 parts of raisin tree seeds; 25-45 parts of mango seeds; 15-30 parts of erigeron breviscapus; 5-20 parts of herba aristolochiae; 10-35 parts of paris rhizome; 10-25 parts of hairyvein agrimony; VB 12 0.001 to 0.01 portion. The raw materials are combined, the effects complement each other, the combined action is to nourish yin and blood, clear heat and eliminate evil, eliminate free radicals in vivo as soon as possible, and simultaneously combine vitamin B 12 The nutritional oral liquid can accelerate the assimilation of the body, provide more nutrition and energy for cardiac muscle cells, promote the development and maturation of the whole erythrocyte, relieve the anemia of the body, expel exogenous evil on the basis of tonifying, achieve the purpose of treating both principal and secondary aspect of disease, and effectively prevent and treat pet viral myocarditis. |
| priorityDate | 2018-11-26^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 103 of 103.